Article Publish Status: FREE
Abstract Title:

Serum 25-Hydroxyvitamin D Concentrations≥40 ng/ml Are Associated with>65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study.

Abstract Source:

PLoS One. 2016 ;11(4):e0152441. Epub 2016 Apr 6. PMID: 27049526

Abstract Author(s):

Sharon L McDonnell, Carole Baggerly, Christine B French, Leo L Baggerly, Cedric F Garland, Edward D Gorham, Joan M Lappe, Robert P Heaney

Article Affiliation:

Sharon L McDonnell

Abstract:

BACKGROUND: Higher serum 25-hydroxyvitamin D [25(OH)D] concentrations have been associated with a lower risk of multiple cancer types across a range of 25(OH)D concentrations.

OBJECTIVES: To investigate whether the previously reported inverse association between 25(OH)D and cancer risk could be replicated, and if a 25(OH)D response region could be identified among women aged 55 years and older across a broad range of 25(OH)D concentrations.

METHODS: Data from two cohorts representing different median 25(OH)D concentrations were pooled to afford a broader range of 25(OH)D concentrations than either cohort alone: the Lappe cohort (N = 1,169), a randomized clinical trial cohort (median 25(OH)D = 30 ng/ml) and the GrassrootsHealth cohort (N = 1,135), a prospective cohort (median 25(OH)D = 48 ng/ml). Cancer incidence over a multi-year period (median: 3.9 years) was compared according to 25(OH)D concentration. Kaplan-Meier plots were developed and the association between 25(OH)D and cancer risk was examined with multivariate Cox regression using multiple 25(OH)D measurements and spline functions. The study included all invasive cancers excluding skin cancer.

RESULTS: Age-adjusted cancer incidence across the combined cohort (N = 2,304) was 840 cases per 100,000 person-years (1,020 per 100,000 person-years in the Lappe cohort and 722 per 100,000 person-years in the GrassrootsHealth cohort). Incidence was lower at higher concentrations of 25(OH)D. Women with 25(OH)D concentrations≥40 ng/ml had a 67% lower risk of cancer than women with concentrations<20 ng/ml (HR = 0.33, 95% CI = 0.12-0.90).

CONCLUSIONS: 25(OH)D concentrations≥40 ng/ml were associated with substantial reduction in risk of all invasive cancers combined.

Study Type : Human Study

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2020 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.